Male (n = 425) | Female (n = 126) | P value | ≤30 years (n = 366) | > 30 years (n = 185) | P value | |
---|---|---|---|---|---|---|
Age, years | 26 (21–34) | 24 (19–34) | 0.11 | 22 (19–25) | 40 (34–46) | < 0.001a |
Females, n (%) | – | – | – | 101 (20.4) | 45 (20.2) | 0.92 |
Level of sport, n (%) | ||||||
Elite level | 235 (55.3) | 70 (55.6) | 1.02 | 297 (60.1) | 112 (50.5) | 0.02b |
Sub-elite level | 189 (44.7) | 56 (44.4) | 197 (39.9) | 110 (49.5) | ||
Duration of symptoms, months | 24 (12–48) | 33 (18–60) | 0.071 | 24 (12–48) | 36 (24–48) | < 0.001a |